Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
|
3 Months Ended |
12 Months Ended |
Mar. 31, 2022 |
Mar. 31, 2021 |
Dec. 31, 2021 |
Dec. 31, 2020 |
| Cash flows from operating activities: |
|
|
|
|
| Net Loss |
$ (2,099,895)
|
$ (534,006)
|
$ (3,888,661)
|
$ (1,450,623)
|
| Adjustments To Reconcile Net Loss To Net Cash Used In Operating Activities: |
|
|
|
|
| Depreciation And Amortization |
1,168,773
|
3,905
|
2,044,447
|
14,698
|
| Share-based Compensation Expense |
|
|
(10,683)
|
374,337
|
| Stock Issued For Compensation |
|
|
160,978
|
150,440
|
| Share-based compensation expense |
43,443
|
94,105
|
|
|
| Loss On Disposal Of Property, Plant And Equipment |
|
|
2,223
|
0
|
| Contract Liabilities |
|
|
59,575
|
0
|
| Changes In Operating Assets And Liabilities: |
|
|
|
|
| Inventory |
(337,805)
|
3,024
|
(3,024)
|
(1,107)
|
| Other current assets |
(297,707)
|
18,254
|
|
|
| Accrued expenses and others current liabilities |
133,302
|
202,981
|
|
|
| Prepaid Expense And Other Current Assets |
|
|
(415,054)
|
(19,020)
|
| Accounts Payable And Accrued Expenses |
|
|
794,174
|
429,510
|
| Acquisition of property and equipment |
(135,899)
|
0
|
|
|
| Net cash used in operating activities |
(1,389,889)
|
(211,737)
|
(1,249,977)
|
(499,551)
|
| Cash Flows From Investing Activities : |
|
|
|
|
| Proceeds from convertible notes payable |
850,000
|
236,854
|
|
|
| Patent Purchases |
|
|
0
|
(7,243)
|
| Proceeds from notes payable |
800,000
|
0
|
|
|
| Acquisition Of Property, Plant And Equipment |
|
|
(143,792)
|
0
|
| Net cash used in investing activities |
(135,899)
|
0
|
(180,517)
|
(7,243)
|
| Payments of other notes payable |
0
|
(37,985)
|
|
|
| Increase In Refundable Deposits And Others |
|
|
(36,725)
|
0
|
| Payments of lease liabilities |
(5,116)
|
0
|
11,799
|
0
|
| Cash Flows From Financing Activities : |
|
|
|
|
| Proceeds From Convertible Note Payable - Related Party |
|
|
3,106,025
|
120,000
|
| Payments Of Other Note Payable |
|
|
(4,605)
|
0
|
| Proceeds From Exercise Of Stock Options |
|
|
64,752
|
0
|
| Payments Of Lease Liabilities |
5,116
|
0
|
(11,799)
|
0
|
| Issuance of convertible notes for payables - related party |
26,000,000
|
0
|
|
|
| Receivable of convertible notes issued |
50,000
|
0
|
|
|
| Net change in equipment payable |
202,002
|
0
|
|
|
| Net cash provided by financing activities |
1,644,884
|
198,869
|
3,154,373
|
120,000
|
| Effect from foreign currency exchange |
754
|
0
|
5,375
|
0
|
| Net change in cash |
119,096
|
(12,868)
|
1,723,879
|
(386,794)
|
| Cash And Cash Equivalents At Beginning Of Period |
1,751,499
|
22,245
|
22,245
|
409,039
|
| Cash and cash equivalents at end of period |
$ 1,871,349
|
$ 9,377
|
1,751,499
|
22,245
|
| Supplemental Disclosures Of Noncash Financing And Investing Activities: |
|
|
|
|
| Cash Paid For Interest |
|
|
19,380
|
855
|
| Stock Issued For Subscription |
|
|
0
|
100,000
|
| Stock Issued For Patent Cost And Accrued Liabilities |
|
|
0
|
144,250
|
| Conversion Of Convertible Notes And Accrued Interest Into Common Stock |
|
|
476,329
|
0
|
| Rou Leased Assets |
|
|
62,903
|
0
|
| Acquisition Of Intangible Assets And Equipment |
|
|
40,226,870
|
0
|
| Decrease Of Additional Paid In Capital |
|
|
5,773,130
|
0
|
| Issuance Of Common Stock And Increase Of Current Liability |
|
|
$ 46,000,000
|
$ 0
|